OBJECTIVES: Recent studies conclude that cardiac surgery patients are prone to both mortality and morbidity in the weeks after discharge. Complications such as pleural and pericardial effusions may influence physical recovery due to symptoms such as dyspnoea, chest pain and fatigue. Dedicated follow-up and timely treatment of postoperative complications are suggested.
INTRODUCTION
Recent studies demonstrate that although 30-day mortality has dropped over the last decade, 1-year mortality remains unchanged, and the mortality rate does not reach a steady state before 120 days after surgery [1] . More than 30% of these early deaths take place out of hospital, with a vast majority being attributed to cardiac disease. Furthermore, readmissions due to cardiac disease are frequent (15-20%) , especially in the early post-discharge period [2, 3] . Current follow-up protocols leave a gap between patient discharges from the cardiothoracic centres to the initiation of outpatient programmes at the heart clinics. Thus, early, dedicated follow-up may hold the potential to detect complications at an early stage, facilitating appropriate treatment and improvement of care.
Pleural effusion (PLE) and pericardial effusion (PE) have incidence rates of 40-85% within the immediate postoperative period [4] [5] [6] . The effusions range from benign and self-limiting to compromising and life threatening, such as tamponade. Although the incidence of tamponade peaks in the first postoperative week, late-onset effusions remain a hazard [5, 7] . Neither PLE nor PE are all-or-none phenomena but rather continuums of haemodynamic and respiratory derangements, and they have been linked to atrial fibrillation [8] , reduced physical capacity [9] [10] [11] , poor sleep quality [12] and impaired left ventricular preload [13] , as well as long-term mortality [14] . The clinical impact of an effusion is not merely dependent on volume, but also on fluid localization, rate of development, concomitant effusions and the patient's general cardiopulmonary condition. Additionally, effusion size is poorly correlated to symptoms such as dyspnoea, vertigo and oxygen demand, as well as to symptom relief after drainage [9, 11] , and the impact on recovery as well as the susceptibility to other complications remains unexplored. Consequently, the threshold of intervention is inconsistent and largely at the discretion of the physician.
In summary, regardless of advances in cardiac surgery and postoperative care, the patients remain prone to adverse events after discharge, and dedicated follow-up protocols are needed. Neglected or clinically mute complications such as postoperative effusions may contribute to impaired recovery, considerable morbidity and even mortality in the months following cardiac surgery.
The primary aim of the present study was to investigate the impact of early outpatient visits including protocolled treatment of PLEs and PEs on recovery measured as walking distance, pulmonary function and quality of life after cardiac surgery.
The secondary aim was to determine the immediate effect of thoracentesis on walking distance and pulmonary function in an attempt to provide recommendations pertaining to treatment of postoperative PLEs.
METHODS

Study design
The study was conducted as a randomized, controlled intervention trial with 1 : 1 randomization to either close postoperative follow-up including protocolled treatment of PLEs and PEs (intervention group) or standard postoperative care (control group). There was a running registration of the overall surgical cohort from which this study population was included. The study was approved by the Central Denmark Region Committees on Biomedical Research Ethics (ID: 1-10-72-246-13) and conducted in accordance with the Helsinki declaration. The protocol was published at clinicaltrials.gov (ID: 1-10-72-246-13), and the consolidated standards of reporting trials (CONSORT) guidelines were followed. Participation was conditioned by written, informed consent.
Setting and population
The study was carried out at Aarhus University Hospital between 18 September 2013 and 13 November 2015. All inclusions, examinations, follow-up visits and interventions were carried out by one primary investigator. Inclusion was carried out in intervals (active study periods) (Fig. 1) . Patients scheduled for elective on-pump coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or combination procedures of CABG and AVR were eligible for inclusion. Exclusion criteria were surgery involving the mitral valve or the aortic arch, simultaneous participation in any other clinical intervention trial and failure to perform a physiological or respiratory test at baseline.
Randomization and blinding
Before the study, an independent research support unit made four sets of 1 : 1 randomized allocations. The sets were then sealed in consecutively numbered opaque envelopes. A patient was randomized at the end of the baseline visit by opening the next sealed envelope to reveal the treatment group. The primary investigator carried out enrolment and intervention assignment.
Study visits
Patients were randomized to either close postoperative follow-up including protocolled treatment of PLEs and PEs (intervention group) or standard postoperative care as described below (control group). As shown in Fig. 1 , all patients were examined the day before surgery (baseline) and 25-30 days after surgery (Visit 3). In between these two visits, the patients in the control group followed the standard postoperative regimen with routine chest X-ray at Day 2 after surgery, and echocardiography upon clinical indication. Thoracentesis was carried out at the attending physician's discretion and did not follow any protocol. The patients included in the intervention group also followed a standard postoperative regimen, but were further subject to examination at Days 3-4 (Visit 1) and Days 10-15 (Visit 2). Visits 1 and 2 took place during hospitalization, and Visits 3 and 4 were carried out on an outpatient basis, but at the site of surgery. The content of each study visit is outlined in Table 1 .
Submaximal functional capacity was assessed through the 6-minute walk test (6MWT) [15] , which was carried out on a plane surface with a rectilinear course. Before and after the test, the degree of dyspnoea was measured by the visual analogue scale (VAS) [16] . At the completion of the test, the achieved walking distance and the heart rate recovery (HRR) time were recorded [17] . Spirometry was carried out using a handheld micro-computerized spirometer with the patient in the sitting position. Peak expiratory flow (PEF), forced vital capacity (FVC) and forced expiratory flow in the first second (FEV 1 ) were obtained, and the FEV 1 /FVC ratio was calculated and adjusted for age, sex and height. Quality of life was assessed with the EuroQOL questionnaire (EQ-5D-3L) [18] . Demographic information, anthropometric parameters, cardiac history, cardiac function assessments, comorbid conditions and medications were retrieved from the patients' medical records.
Point of care (POC) sonography was performed using a 2.5-MHz phased-array transducer connected to an S6 ultrasound machine (GE Healthcare, Horten, Norway). Images were obtained at bedside with a POC protocol with five standard views (Fig. 2 ) [19] . The ejection fraction (EF) was evaluated by means of eyeballing and tracking of wall motion. All cine loops were stored for offline analyses. In 20 random patients, analyses were repeated to assess intra-observer variability. A second person, also blinded, repeated all analyses from 20 randomly selected patient datasets for the calculation of inter-observer variability.
Pleural effusions
Patients were investigated supine with mild trunk elevation at 15°. The maximal distance D between the parietal and visceral pleura (Fig. 3) was measured offline at the lung base in end-expiration, and the volume of pleural fluid was quantified by the formula V (ml) = 20 × D (mm) [20] . In the intervention group, thoracentesis was performed in case of an estimated PLE above 400 ml or a PLE below 400 ml with symptoms of respiratory distress. PLEs < 400 ml without symptoms were left untreated. Study examinations were carried out before and after the procedure to measure possible effects. If protocolled for drainage, the procedure was carried out under local anaesthesia and guided by dynamic ultrasound. With real-time sonography guidance of needle placement [21] [22] [23] , we did not pause warfarin or other anticoagulants, nor did we run blood analyses before thoracentesis. A 14-G calibre syringe was inserted into the pleural cavity and the effusion was drained into a bag using a three-way valve. The volume of fluid (V) was recorded and the tap was terminated when no more fluid could be aspirated, or when volume reached 1500 ml. Cine loops of the pleura were obtained before and after intervention to evaluate the residual fluid volume as well as signs of pneumothorax (absence of lung sliding or seashore pattern [24] ). Patients were observed for 30-60 min after termination of the tap; thereafter they were sent home with instructions to contact the hospital in case of progressive dyspnoea, dizziness or fatigue. In case of large PLEs detected with chest X-ray, high oxygen demand or symptoms of dyspnoea, the attending physician was allowed to initiate treatment, regardless of group assignment, and at his or her discretion.
Pericardial effusions
In case of PE, the effusion was evaluated based on location and maximal diameter in end-diastole. The presence of a localized PE above 20 mm, a circumferential PE above 15 mm or a PE of any size with clinical symptoms or compromised cardiac function visualized by sonography prompted consultation with either a cardiologist or thoracic surgeon. This applied to all patients regardless of group assignment.
Outcomes
The primary outcomes were the differences in the mean change between groups in walking distance, PEF and the quality of life from baseline to the final visit.
The secondary outcomes were the mean difference in walking distance and the mean difference in PEF measured before and after thoracentesis at Visit 2 and Visit 3 (intervention group only).
Statistical analyses
All analyses concerning the primary end-points were conducted on the per-protocol population defined as patients with a valid baseline and a valid Visit 3. Analyses concerning the secondary end-points were conducted on patients who underwent protocolled thoracentesis in the intervention group. Categorical variables were expressed as frequencies and percentages and compared using a proportion test, Pearson's χ 2 or Fisher's exact test. Continuous variables were expressed as mean ± standard deviation (SD) and percentages as appropriate, and compared by unpaired or paired Student's t-test and Mann-Whitney U-test. Linear regression was used for correlation analyses.
The assumption of normality was tested with QQ plots, and log-transformation was applied if suitable. Inter-and intraobserver variability was tested using compliance rates for binary outcomes and Bland-Altman plots as well as one-way ANOVA for continuous outcomes and repeated measurements. A P < 0.05 was considered statistically significant. All statistical analyses were performed using Stata 14.1.
Sample size and power calculation
It was determined that a sample size of 32 patients in each group provided 80% power (α = 0.05) to detect a between-group difference in walking distance, considering a mean difference of 15% clinically significant, and provided 90% power (α = 0.05) to detect at difference of 30% in 6MWT and PEF before and after thoracentesis in the intervention group. Initially, the sample size was based on an incidence rate of PLEs of 10% [4] when screening with conventional X-ray. The sample size was later adjusted corresponding to incidence as reported by Christiansen et al. [7] . To allow for 15% withdrawals, death and major protocol deviations, we randomized a total of 76 patients.
RESULTS
A total of 76 patients were included into the study. Eleven patients (14.5%) dropped out before the final visit, leaving 65 patients for the per-protocol analyses. All dropouts were due to withdrawal of consent due to general fatigue and lack of energy. The dropouts did not differ significantly from the study population. As demonstrated in Table 2 , the study population was less likely to suffer from preoperative angina pectoris, and more likely to undergo isolated AVR compared with the overall surgical cohort. Otherwise, the study population did not differ from the surgical cohort. Comparing the intervention group with the control group, we found no statistically significant differences in age, gender, preoperative morbidity or procedural data (Table 3) .
Primary end-points
All measurements from baseline and Visit 3 are recounted in Table 4 . The patients in the control group had a mean percentagewise change in walking distance of −3 ± 22% from baseline to the final visit. The intervention group had a mean percentage-wise change of walking distance of 12 ± 26% from baseline to the final visit, yielding a difference between groups of 15%, P = 0.017. The mean PEF was significantly different between groups at Visit 3. However, the mean change of PEF from baseline to the final visit was −5 ± 43% in the control group and −3 ± 29% in the intervention group, and thus, the difference in the mean change between groups was not significant. Likewise, vital parameters, EF, HRR, FEV 1 , FVC and self-reported dyspnoea showed no variation between groups when comparing changes from baseline to the final visit.
Self-reported quality of life showed no variation between groups when comparing changes in the total score from baseline to the final visit. When comparing changes in the individual dimensions of the EQ-5D-3L, we found a significant difference of 20% between groups in the dimension 'Self care'; however, significant differences were found neither in the dimensions 'Mobility', 'Daily activities', 'Pain' or 'Anxiety' nor in VAS of overall health status.
Postoperative effusions
A total of 28 patients (43%) in the per-protocol population underwent thoracentesis at least once in the study period, and 45 PLEs were drained, out of which 22 were by protocol and 23 were a result of routine screening with X-ray or by clinical indication. Consequently, supplemental POC sonography improved detection and treatment of PLEs by 56%. Six patients (9%) developed subacute or acute PEs, three of which were diagnosed and immediately surgically treated as a direct result of the study. In all 3 cases, the patients presented only mild functional dyspnoea and unaffected vital signs despite severe haemodynamic impact on heart chambers.
Events outside protocol
In addition to the protocolled events, 14 patients needed treatment adjustments, expediting of control visits or hospitalization due to postoperative complications: 9 patients in the intervention group and 5 patients in the control group. The 30-day readmission rate was 32% (n = 21). More than half (52%) of the readmissions could be attributed to cardiac causes, 24% to PLEs and 24% to other postoperative complications (infection, thromboembolism, dyscoagulation). The 30-day mortality rate was 0%.
Secondary end-points
In the intervention group, 22 PLEs were protocolled for intervention; however, 5 of them were carried out at Visit 1 and the patients were thus not subjected to a 6MWT and spirometry. The remaining 17 PLEs concluded the analyses for the secondary endpoint. Measures before and after intervention are presented in Table 5 . The mean drained volume was 888 ± 416 ml. The mean difference in walking distance before and after thoracentesis was 81 ± 42 m corresponding to a 22% improvement, P < 0.001. The improvement in walking distance was positively correlated to the volume drained, P = 0.003. The mean difference in PEF before and after thoracentesis was 1.1 ± 1.2 l/min corresponding to a 26% increase, P < 0.001. The mean differences in FVC and FEV 1 were 0.36 ± 0.32 l and 0.28 ± 0.20 l/first second, P < 0.001 and P = 0.002. The difference in PEF was not correlated to the volume drained.
The respiratory rate at rest, VAS at rest and saturation at rest and after the 6MWT were all significantly improved after intervention. The size of PLE was neither correlated to self-reported dyspnoea at rest nor after the 6MWT. At rest, self-reported dyspnoea either remained unchanged or decreased after intervention (P = 0.001), whereas the effect on self-reported dyspnoea after the 6MWT was All patients who had relevant surgery in the entire inclusion period but who were not included in the study. insignificant. We detected no complications associated with thoracentesis.
DISCUSSION
The present study establishes that compared with standard postoperative care, complementary follow-up visits including screening with POC sonography and treatment of postoperative effusions improve the physical recovery rate by 15%, measured by the mean change in walking distance from the day before surgery to 30 days after surgery. The additional controls had no effect on pulmonary capacity measured by PEF, or on the overall selfreported quality of life. Walking distance in the 6MWT has been determined as an independent predictor of both morbidity and mortality in cardiac patients across a wide range of clinical conditions and settings. Beatty et al. [25] demonstrated a 55% higher rate of any cardiovascular event with each SD decrease in walking distance in patients with stable coronary heart disease. Although the patients examined in the present study are in the dynamic postoperative phase of their cardiac disease, the improved walking distance may have implications on long-term outcome. The study furthermore demonstrates that drainage of PLEs after cardiac surgery has an immediate impact on physical capacity Effusion size: maximal distance between parietal and visceral pleura measured in end-expiration; 6MWT: 6-min walk test; Heart rate return: time in minutes from maximal heart rate after 6MWT to heart rate at rest ± 3 b.p.m.; PEF: peak expiratory flow; FVC: forced vital capacity; FEV 1 : forced expiratory volume in the first second; VAS: visual analogue scale.
with a mean improvement in walking distance of more than 22%. To the knowledge of the authors, this association has not previously been established, even though it is supported by findings in other patient populations [10] . Although we demonstrated an immediate improvement in PEF of 26% after thoracentesis, which is in accordance with previous findings [26], we were not able to demonstrate a difference in pulmonary function between groups. Thus, the mean improvement in walking distance from baseline to the final visit cannot be readily explained by better pulmonary function measured by spirometry. Unilateral PLEs have been demonstrated to have substantial haemodynamic impact in animal models [27] , resulting in decreasing preload, stroke volume, cardiac output, mean arterial pressure and mixed venous saturation. This implies that the restriction on physical capacity associated with PLEs is likely to be caused by more than respiratory distress; however, research concerning the effects of PLEs on cardiopulmonary physiology and symptomatology in humans is sparse [9] . We detected no between-group difference in the EF from baseline to the final visit. Previously, negative impact on longitudinal strain has been demonstrated [28] despite unaffected EF, extending up to 6 months after cardiac surgery. Neither measures on wall motion nor global EF is specific to the sub-endocardial, longitudinal muscle fibres, and since these fibres are the most sensitive to the ischaemia and reperfusion injuries associated with cardiopulmonary bypass, future studies may benefit from more sophisticated methods when evaluating cardiac function after cardiac surgery. PLEs have been associated with atrial fibrillation [8] , impaired left ventricular preload [6, 13] , low threshold of physical exertion and poor sleep quality [12] , all of which can affect physical recovery and increase the need for bed rest. Postoperative immobilization enhances the risk of other complications such as pneumonia, oedema, venous thromboembolism and loss of lean body mass. Thus, PLEs may not be a mere postoperative inconvenience, and thoracentesis has the potential to enhance overall recovery in selected patients, although dedicated randomized trials are needed.
In the present study, all patients experienced improvements in physical capacity. The cut-off volume for intervention was set relatively low to include the broadest possible spectrum of postoperative effusions. Although the size of effusion did correlate with the improvement in walking distance, we were not able to demonstrate a clear, clinical cut-off volume for drainage in the studied population. Even though minor PLEs have been associated with an increased risk of complications, safety has greatly increased with the use of ultrasound guidance [21] . Nonetheless, careful consideration is necessary in case of loculated or very small effusions. In concordance with studies on the safety of thoracentesis [29, 30] , we did not pause anticoagulant treatment before intervention. Nevertheless, in the course of thoracentesis, you navigate in close proximity to vital structures. Although the complication rate is relatively low in ultrasound-guided thoracentesis, the risk of harm should always be considered and weighed against the expected improvements in the patients' condition.
We were not able to correlate the size of effusion to selfreported dyspnoea, saturation or PEF, neither at rest nor under strain, which stresses the conclusion that we should not rely on respiratory symptomatology alone but should take other measures into account, when deciding to perform thoracentesis.
Overall, 9% of the patients developed haemodynamically compromising PEs and were subsequently drained. Three of the patients were diagnosed and treated as a direct consequence of the study examinations, two of them almost a month after surgery.
The patients had limited symptoms despite considerable effusions and severely compromised cardiac function, which is in accordance with the literature [5, 11] . Our findings confirm that tamponade is an unpredictable, highly dangerous condition that may yield little or no warning of looming collapse. Late-onset effusions are likely underestimated and may contribute to both morbidity and mortality. In addition to postoperative effusions, the additional follow-up visits disclosed unrecognized pathology in more than one out of five patients. These un-protocolled events ranged from minor complications easily handled with adjustments of medications to potentially fatal complications such as pulmonary emboli and heart failure. The present study was not designed to evaluate the impact of close follow-up on the complication rate or mortality; however, the large proportion of patients suffering from adverse events indicate that greater priority to early, specialized follow-up could very well improve patient care in the months after cardiac surgery.
Conventionally, chest X-ray is used to screen for postoperative PLE, although the limitations of the modality have been widely acknowledged. The sensitivity of X-ray compared with other imaging modalities has been investigated several times, showing X-ray to have a significantly lower sensitivity than computer tomography (CT) and sonography, both in respect of detection of PLEs and estimation of size [4] . In contrast to CT, POC sonography can be performed at bedside by the attending physician, is rapidly accomplished and can be repeated serially without any radiation risk. Sonography furthermore improves the detection of PEs, and offers a crude assessment of cardiac function as well as major pathology. Supplementing or substituting X-ray with the use of POC sonography as a standard part of ward rounds and follow-up consultations would aid the detection of both PLEs and PEs, and enhance diagnostic accuracy and suitable treatment [7, 19] .
Limitations of the study
We were not able to perform a double-blinded randomized trial due to the nature of the intervention. To compensate, outcome assessment was performed with the investigators blinded to group assignment. Out of 360 possibly eligible patients in the periods of active inclusion, 50% of the patients were screened, and the final enrolment rate was 21%. This is a significant limitation of the study and regretfully it has an impact on the level of evidence. The low enrolment rate was due to several factors, such as having to compete with other studies for the same group of patients, and all study elements being carried out by a single investigator. We observed a very high prevalence of postoperative effusions in the studied population, which may be partly explained by the low cut-off volume for intervention. Similar numbers have been reported in a study screening patients at regular intervals in the first month after surgery [7] . However, the low enrolment rate enhances the risk of selection bias, and although we demonstrated few significant differences between enrolled patients and the general population of cardiac surgery patients, we did detect a higher proportion of patients subjected to AVR in the study population, who are more likely to receive oral anticoagulants and may be more prone to develop postoperative effusions. Nevertheless, we did not detect any difference in anticoagulant treatment between groups. A large fraction of the postoperative effusions was developed after discharge and the correlation between symptoms and effusion size was poor. Consequently, we are likely to underestimate the true prevalence of PLEs in the post-cardiac surgery population, if we do not intentionally look for them.
Patients admitted for emergency procedures and patients unable to perform the exercise tests at baseline were excluded from the study. Subjects enrolled in the study represent a selected group of cardiac surgery patients, and our conclusions should be extended to the overall surgical cohort with care. An obvious limitation of the study is the lack of examinations between baseline and the final visit in the control group, leaving a blind spot concerning the natural course of PLEs in the named period. Therefore, we do not know the causality between treatment of PLEs and improvements in physical recovery from baseline to the final visit, as other factors associated with close follow-up visits such as treatment adjustments and educational elements may play a role. To truly investigate the effect of thoracentesis, patients should have been randomized to either treatment or observation; however, several ethical issues made us refrain from that option.
CONCLUSION
Complementary follow-up including treatment of PLEs enhances the recovery rate measured as the mean improvement in walking distance 30 days after surgery. Thoracentesis immediately improves walking distance and pulmonary function in patients with postoperative PLEs larger than 400 ml. POC sonography greatly aids the diagnosis of PLEs and PEs, as well as other major cardiopulmonary pathologies, supporting a shift towards the routine use of POC protocols both during primary hospitalization and in the month after cardiac surgery.
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